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Francisella tularensis has developed a number of effective evasion strategies to
counteract host immune defenses, not the least of which is its ability to interact with
the complement system to its own advantage. Following exposure of the bacterium to
fresh human serum, complement is activated and C3b and iC3b can be found covalently
attached to the bacterial surface. However, the lipopolysaccharide and capsule of the
F. tularensis cell wall prevent complement-mediated lysis and endow the bacterium with
serum resistance. Opsonization of F. tularensis with C3 greatly increases its uptake by
human neutrophils, dendritic cells and macrophages. Uptake occurs by an unusual
looping morphology in human macrophages. Complement receptor 3 is thought to
play an important role in opsonophagocytosis by human macrophages, and signaling
through this receptor can antagonize Toll-like receptor 2-initiated macrophage activation.
Complement C3 also determines the survival of infected human macrophages and
perhaps other cell types. C3-opsonization of F. tularensis subsp. tularensis strain SCHU
S4 results in greatly increased death of infected human macrophages, which requires
more than complement receptor engagement and is independent of the intracellular
replication by the pathogen. Given its entry into the cytosol of host cells, F. tularensis
has the potential for a number of other complement-mediated interactions. Studies on
the uptake C3-opsonized adenovirus have suggested the existence of a C3 sensing
system that initiates cellular responses to cytosolic C3b present on invading microbes.
Here we propose that C3 peptides enter the cytosol of human macrophages following
phagosome escape of F. tularensis and are recognized as intruding molecular patterns
that signal host cell death. With the discovery of new roles for intracellular C3, a better
understanding of tularemia pathogenesis is likely to emerge.
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Francisella tularensis is the bacterial pathogen responsible for the infectious disease tularemia.
While tularemia is relatively rare, infection via the respiratory route can be particularly life-
threating when not treated with appropriate antibiotics in a timely fashion (Stuart and Pullen, 1945;
McCrumb, 1961; Dennis et al., 2001; Feldman et al., 2001). There are two subspecies of F. tularensis
that account for the majority of infections in immunocompetent human beings. F. tularensis subsp.
tularensis (type A) is considered the more virulent and will be the primary focus of this article.
F. tularensis subsp. holarctica (type B) is also pathogenic in humans, but is less often associated
with severe morbidity or mortality. Francisella novicida causes a tularemia-like disease in mice, but
rarely infects human beings where disease is restricted to the immunocompromised (Kingry and
Petersen, 2014). Following exposure to type A and type B F. tularensis by the pulmonary route,
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macrophages are among the first cells infected (Hall et al., 2008;
Roberts et al., 2014; Steiner et al., 2017) and serve as an early and
continuing replicative niche for the pathogen. Many receptors
on the macrophage surface have been implicated in the uptake
of F. tularensis (Clemens et al., 2005; Balagopal et al., 2006;
Pierini, 2006; Schulert and Allen, 2006; Barel et al., 2008; Geier
and Celli, 2011; Schwartz et al., 2012; Dai et al., 2013), but
complement receptors, especially CR3, have consistently been
found to be the primary mediators of enhanced uptake of serum-
opsonized F. tularensis by human macrophages (Clemens et al.,
2005; Schwartz et al., 2012; Dai et al., 2013). Once inside the
cell, F. tularensis escapes the macrophage phagosome at a pace
that varies with host species and replicates in the cytosol to high
numbers (Golovliov et al., 2003; Clemens et al., 2004; Chong et al.,
2008).
Macrophage death is a common outcome following in vivo
infection with F. tularensis and partially explains the appearance
of necrotic foci in the livers, lungs, spleens and lymph nodes
in several mammalian species (Parmely et al., 2009). The
mechanisms and significance of macrophage death depend on
the (sub)species of Francisella studied (Mariathasan et al., 2005;
Henry et al., 2007; Wickstrum et al., 2009). For example,
F. novicida is a highly proinflammatory pathogen, which induces
rapid cell death in mouse macrophages that limits the ability
of the bacteria to replicate in the host (Mariathasan et al.,
2005; Henry et al., 2007). When describing the lifecycle of type
A and type B F. tularensis, it is not uncommon to attribute
macrophage death to an uncharacterized signal associated with
the extensive cytosolic replication of the pathogen. For example,
Lai et al. reported on the effects of antibiotic treatment of
J774.A1 macrophage-like cells infected with the F. tularensis
Live Vaccine Strain (LVS) (Lai et al., 2001). Treating cultures
with ciprofloxacin within the first 12 h of infection prevented
both the replication of the bacteria and host cell death
measured 24 h post-infection (PI). If ciprofloxacin treatment
was delayed until 15 h PI, host cell death at 24 h PI was
similar in magnitude to that of untreated, infected control cells.
The authors concluded that intracellular bacterial replication
was required for the induction of macrophage death. Recent
studies performed in our laboratory with type A F. tularensis
(Brock and Parmely, 2017) have questioned this interpretation.
Intracellular replication of the SCHU S4 strain did not appear
to be required for the induction of death in primary human
macrophages.
During the course of these studies, we found that complement
C3 played an important role in determining the survival of
infectedmacrophages. Accordingly, in this article we review what
is known about the interactions between F. tularensis and the
complement system, discuss recent findings about the functions
of intracellular complement, and propose new ways of thinking
about the complement system in tularemia. Our primary focus
will be on F. tularensis subsp. tularensis, although our use of
Abbreviations: BMM, bone marrow-derived macrophage; CR, complement
receptor; FB, factor B; FD, factor D; FI, factor I; HS, human serum; MDM,
monocyte-derived macrophage; MOI, multiplicities of infection; PI, post-
infection.
the designation F. tularensis reflects an effort to include relevant
studies performed with subsp. holartica strains. We acknowledge
this comes with the risk that future studies may prove some
conclusions to be too inclusive.
EXTRACELLULAR COMPLEMENT
ACTIVATION AND REGULATION
For detailed descriptions of complement activation, the reader
is referred to several excellent reviews (Dunkelberger and Song,
2010; Ricklin et al., 2010; Noris and Remuzzi, 2013). There
are three pathways of complement activation (Figure 1), all
of which result in the proteolytic cleavage of complement
component C3, an abundant serum protein. The classical and
lectin pathways both generate a C3 convertase composed of
the peptides C4b and C2a. Through the classical pathway, IgM
and IgG antibodies, when bound to their respective antigens,
bind C1q and initiate the assembly of the C1qr2s2 complex.
This complex cleaves C4 and C2 to produce a C3 convertase,
designated C4bC2a. In the lectin pathway, the binding of
certain carbohydrate patterns on microorganisms by either
serummannose-binding lectin (MBL) or ficolin proteins recruits
and activates mannose-binding lectin-associated serine proteases
(MASPs), which cleave C4 and C2 to generate the same C3
convertase. The alternative pathway is constitutively active with
a low level “tick-over” of C3 in which an internal thioester bond
is spontaneously hydrolyzed yielding C3(H2O). Hydrolyzed C3
has a conformation similar to C3b (Chen et al., 2016) and
can bind complement factor B (FB). Constitutively active factor
D (FD) then cleaves FB, yielding an alternative pathway C3
convertase designated C3(H2O)Bb. Like the C4b2a convertase,
the alternative pathway convertase can cleave C3 to produce
a bioactive short C3a peptide and a lengthier C3b peptide
(Figure 2). C3a can serve as an anaphylatoxin. One of the
primary functions of C3b is as a potent opsonin, which is
attributed to its exposed thioester bond. Unless C3 has been
spontaneously hydrolyzed by water, the C3b thioester can react
with amine or hydroxyl groups. Formation of amide or ester
linkages assures covalent attachment of C3b to nearby target
surfaces, which makes them stable ligands for complement
receptor-mediated uptake.
The alternative pathway also serves to amplify complement
activation initiated by any of the three pathways by
utilizing C3b as a focus for the formation of additional
C3 convertases. Thus, C3b bound to a surface can form
a complex with FB, which when cleaved by FD, becomes
the new alternative pathway C3 convertase C3bBb. This
amplification process results in increased localized activation
of complement in proximity to susceptible microbial
surfaces.
The binding of C3b to C3 convertases changes their specificity
to C5-cleaving enzymes. Proteolysis of C5 produces the peptides
C5a (another anaphylatoxin and potent chemotactic factor) and
C5b, which initiates formation of the membrane attack complex.
C5b binds C6, which then complexes with C7 and inserts
into lipid membranes. The C5b67 complex then interacts with
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FIGURE 1 | Pathways of extracellular complement activation.
C8, followed by recruitment of multiple copies of C9, which
polymerize to form a membrane pore, followed by rapid cell
lysis.
Complement activation is tightly regulated by a variety of
serum and membrane-bound proteins that control the three
complement pathways (reviewed in Zipfel and Skerka, 2009;
Noris and Remuzzi, 2013). The primary outcome is to limit
host tissue damage that would result from unabated complement
activation. Only two of these regulatory components will
be mentioned here. Factor I (FI) is a serum protein that,
along with certain cofactors, cleaves the alpha chain of C3b
yielding inactivated C3b (iC3b) (Figure 2). The formation of
iC3b terminates amplification of the complement cascade by
preventing formation of additional C3 convertases and also halts
C5 cleavage, which diminishes assembly of the membrane attack
complex. However, iC3b retains its opsonic activity, albeit with
different complement receptor specificity than that of C3b. Factor
H (FH) serves as a co-factor for FI and also competes with FB
binding to C3b, preventing formation of the alternative pathway
C3 convertase.
CELL SURFACE RECEPTORS FOR C3
In addition to fluid phase complement factors, there are many
membrane bound complement receptors that are important for
complement regulation and complement-mediated clearance,
phagocytosis and cellular signaling. Here we will discuss
membrane bound complement receptors that have been shown to
have important implications for F. tularensis virulence and host
defense. For a comprehensive review of complement receptors,
the reader is referred to two important reviews (Leslie, 2001;
Zipfel and Skerka, 2009). Complement receptor 1 (CR1or
CD35) is expressed on leukocytes and erythrocytes and binds
C3b (Table 1). In addition to its role in complement-mediated
opsonophagocytosis, CR1 serves as a membrane-bound cofactor
for FI, leading to conversion of C3b to iC3b. CR3 is a heterodimer
of the membrane proteins CD11b and CD18 and is expressed on
neutrophils, macrophages, follicular dendritic cells, eosinophils,
basophils, NK cells and platelets. CR3 shows high affinity for
iC3b, which facilitates phagocytosis of iC3b-bearing particles.
While we will focus primarily on the opsonic activities of these
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FIGURE 2 | Simple schematic of C3 processing. Adapted from (Nishida et al.,
2006).
receptors, CR3 also plays a role in leukocyte trafficking to sites
of infection and regulating cellular responses initiated by certain
Toll-like receptors. CR4 is comprised of heterodimers of CD11c
and CD18 and is expressed onmonocytes andmacrophages. CR4
also binds iC3b with high affinity.
Apart from the involvement of complement receptors in the
uptake of F. tularensis by phagocytic cells, little research has
investigated the role of other cell surface complement receptors
and regulators. For example, tissue macrophages also express
the complement receptor CRIg, which binds the beta chain of
C3, allowing the receptor to phagocytize both C3b- and iC3b-
opsonized particles. CRIg is important for the clearance of
pathogens (Helmy et al., 2006; van Lookeren Campagne et al.,
2007), but its role during F. tularensis infection has not been
investigated. Mature B cells express CR2 (or CD21), which binds
iC3b, C3dg and C3d peptides derived from FI-mediated cleavage
of iC3b. One report suggests that subsets of mouse B cells employ
CR2 along with the B cell receptor for uptake of F. tularensis
(Plzakova et al., 2015). CD46, CD55 and CD59 are expressed by
most host cell types, regulate complement activation and protect
host tissues from complement-mediated damage by aiding in the
inactivation of C3, disrupting the C3 convertases or preventing
the formation of the membrane attack complex, respectively.
Whether or not these complement regulators play a role in
F. tularensis virulence or host defense is unknown.
INTRACELLULAR ACTIONS OF
COMPLEMENT
Based on phylogenetic studies and the presence of C3-
like proteins in porifera (sponges), Elvington et al. have
suggested that complement proteins served first to protect the
intracellular space before evolving into a system for defending
against pathogens at the cell membrane or in intercellular or
intravascular domains of higher organisms (Elvington et al.,
2016). Only recently have we begun to appreciate the extent to
which complement mediates important intracellular functions
(reviewed in Arbore et al., 2017; Liszewski et al., 2017).
Many cell types produce C3 (Lubbers et al., 2017) and
maintain intracellular stores of the protein (Liszewski et al.,
2013). Elvington et al. recently showed that intracellular C3
derives from a C3(H2O) recycling pathway in which hydrolyzed,
but not native, C3 is taken up from the extracellular environment
(Elvington et al., 2017). After being loaded with C3(H2O),
Farage B lymphoma cells released ∼80% of the C3(H2O) back
into the culture medium, suggesting that the cells processed
the remainder as a source of bioactive C3 peptides (Liszewski
et al., 2013; Elvington et al., 2017). Complement receptors CR1,
CR2, CR3, and CD46 did not appear to be involved in the
uptake of C3(H2O) in this recycling pathway (Elvington et al.,
2017).
Liszewski and colleagues have extensively documented
mechanisms of C3 activation within cells (Liszewski et al., 2013).
For example, cathepsin L can cleave C3 to form C3a and C3b
within the lysosomes of human T cells. The resulting C3a
mediates the tonic intracellular activation of its complement
receptor C3aR on the lysosome membrane, leading to baseline
mTOR activation necessary for T cell homeostasis. Inhibition
of cathepsin L or siRNA inhibition of C3aR expression led to
T cell apoptosis. Activation of T cells through their antigen
receptors resulted in the transport of vesicles containing C3aR,
C3 and cathepsin L to the cell surface. In an autocrine fashion,
cleavage of C3 at the cell surface and binding of C3a and C3b
to their respective receptors, C3aR and CD46, polarized the T
cell to a Th1 phenotype (Liszewski et al., 2013; Kolev et al.,
2015).
Intracellular activation of C3 is not limited to T cells. It
has also been demonstrated in a variety of primary human cell
types including monocytes, neutrophils, and B cells, as well as
cultured human fibroblasts, ME-180 epithelial cells and umbilical
vein endothelial cells (Liszewski et al., 2013). The proteases
responsible for intracellular C3 cleavage vary among cell types.
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TABLE 1 | Human complement receptors with known involvement in the uptake of serum-opsonized F. tularensis.
Complement receptor Preferred ligand* Cell expression* Function in F. tularensis infection References
CR1 (CD35) C3b, C4b Leukocytes (including neutrophils and
macrophages) and erythrocytes
Uptake of serum-opsonized F. tularensis
by human neutrophils
Schwartz et al., 2012
CR3 (CD11b, CD18) iC3b Neutrophils, macrophages, follicular
dendritic cells, eosinophils, basophils, NK
cells and platelets
Uptake of serum-opsonized F. tularensis
by human neutrophils, macrophages and
dendritic cells
Crosstalk with TLR2–inhibition of
TLR2-mediated inflammatory signaling
Clemens et al., 2005; Ben
Nasr et al., 2006; Schwartz
et al., 2012; Dai et al., 2013
CR4 (CD11c, CD18) iC3b Monocytes and macrophages Uptake of serum-opsonized F. tularensis
by macrophages and dendritic cells
Ben Nasr et al., 2006;
Schwartz et al., 2012
*Receptor ligand specificity and cell expression obtained from Leslie (2001) and Zipfel and Skerka (2009).
While cathepsin L mediates activation of C3 in T cells and
monocytes, it is not responsible for the C3 activation observed
in lung epithelial cells (Liszewski et al., 2013). Both cathepsin
L and cathepsin B contribute to C3 cleavage within human
intestinal epithelial cells (Satyam et al., 2017). Factor H and FI
can be taken up by cells and mediate intracellular cleavage of
C3(H2O) (Elvington et al., 2017). FactorH has also been shown to
interact with cathepsin L to increase cleavage of endogenous C3
yielding iC3b (Martin et al., 2016). Clearly, additional studies are
needed to form a complete understanding of the significance of
intracellular complement activation and its potential relationship
with host defense.
Tam and colleagues demonstrated that the presence of C3
peptides in the cytosol may also serve as molecular patterns
that initiate danger signaling (Tam et al., 2014). A variety
of C3-opsonized microbes, including both RNA and DNA
non-enveloped viruses and the ∆sifA mutant of Salmonella,
activated a NF-κB-driven luciferase reporter when present in
the cytosol. The reporter was not activated when cytosolic entry
was prevented or when pathogens were not opsonized with
C3. Latex beads opsonized with a mixture of purified C3, FB
and FD also activated NF-κB when transfected into HEK293T
cells, suggesting that recognition of microbial patterns was
not essential for this response. Signaling initiated by cytosolic
C3 was independent of the signaling intermediates MyD88,
TRIF, RIG-I, MDA5, Syk, and STING, but appeared to involve
the mitochondrial antiviral signaling (MAVS) protein and
TNF receptor-associated factor (TRAF). Cytosolic C3 sensing
was observed in a variety of non-immune mammalian cell
lines indicating that the proposed C3-detection pathway may
be active in a number of cell types. However, it remains
unknown whether macrophages sense cytosolic C3 in this
manner. It should also be noted that these findings have
not, as yet, been confirmed by other investigators and that
a putative cytosolic C3 sensor has not yet been identified.
This laboratory has identified tripartite motif-containing 21
(TRIM21) as a cytosolic sensor for IgG and IgM that also
leads to the activation of NF-κB and interferon regulatory
factors (James et al., 2007; Mallery et al., 2010; McEwan et al.,
2013). The notion that C3 peptides mediate similar intracellular




In the conventional sense, F. tularensis is relatively serum
resistant, meaning that it can survive in human serum (HS)
without succumbing to the lytic effects of complement (Lofgren
et al., 1983; Sorokin et al., 1996). Serum resistance appears
to be conferred by the lipopolysaccharide (LPS) and cell
wall structure of F. tularensis, as evidence by the increased
activation of complement (especially via the classical pathway)
and susceptibility to serum-mediated lysis of LPS and capsule
mutants (Sandstrom et al., 1988; Sorokin et al., 1996; Clay et al.,
2008; Lindemann et al., 2011). It is possible that mutations
in other F. tularensis genes similarly alter the density of iC3b
deposition following serum opsonization. Additionally, growth
of F. tularensis in different culture media, which can alter
the expression of high molecular weight surface carbohydrates,
can affect the extent of C3 deposition on the bacterial surface
(Zarrella et al., 2011). During opsonization of F. tularensis in
HS, FH can bind to serum-opsonized F. tularensis (Ben Nasr
and Klimpel, 2008), promoting the conversion of C3b to iC3b.
This prevents the assembly of the membrane attack complex on
the bacterial surface (Ben Nasr and Klimpel, 2008; Clay et al.,
2008). F. tularensismay also express a surface CD59-like peptide
(Madar et al., 2015), which may further hinder formation of the
membrane attack complex by binding C8 or C9.
Several reports indicate that both the classical and alternative
pathways are activated by F. tularensis (Ben Nasr and Klimpel,
2008; Clay et al., 2008) and include the observation that C1q
is required for C3 deposition on the bacterium under certain
conditions (Fulop et al., 1993; Clay et al., 2008; Schwartz
et al., 2012). Natural IgM antibodies appear to play a role
in complement activation by F. tularensis via the classical
complement pathway (Sandstrom et al., 1988; Schwartz et al.,
2012). Schwartz et al. showed that human serum (HS) from
donors without a history of tularemia contained IgM antibodies
that reacted with F. tularensis andmediated C3 deposition during
the first 30min of opsonization. Ben Nasr and Klimpel (2008)
reported that, although the classical pathway was activated, they
were unable to detect binding of serum IgM to F. tularensis.
Balagopal et al. (2006) used immunofluorescence and ELISA to
detect antibodies bound to F. novicida following opsonization of
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the bacteria with HS. The differences between these reports may
reflect the bacterial strains that were studied or the use of different
techniques to detect antibody binding. Regardless, there appears
to exist sufficient evidence to conclude that the classical pathway
can mediate C3 opsonization of F. tularensis.
The classical pathway may be particularly important when
serum opsonization occurs for periods of <30min. Longer
periods of incubation with serum may allow significant
alternative pathway amplification and C3b deposition (Ben Nasr
and Klimpel, 2008). We have found that uptake of F. tularensis
SCHU S4 by human macrophages over 3 h is significantly
reduced in C3-depleted HS compared to HS (Brock and Parmely,
2017). However, there is no difference in the level of SCHU S4
uptake during a 3-h incubation in C1q-depleted HS compared
to HS (Brock and Parmely, unpublished). Likewise, Ben Nasr
and Klimpel (2008) reported that EGTA chelation of Ca2+ ions
necessary for classical pathway activation in HS delayed the
deposition of iC3b on F. tularensis if opsonization was limited
to 30min. After 45min of opsonization, there was no difference
between the levels of iC3b deposition that occurred in HS and
EGTA-treated HS (Ben Nasr and Klimpel, 2008). Conversely,
treatment of HS with EDTA, which chelates both Ca2+ andMg2+
and blocks both classical and alternative pathways, prevented any
detectable iC3b deposition on SCHU S4 for at least 1 h (Ben Nasr
and Klimpel, 2008). Thus, it appears that both the classical and
alternative pathways can mediate complement activation during
serum opsonization of F. tularensis.
COMPLEMENT-MEDIATED UPTAKE OF
F. TULARENSIS
For a more comprehensive summary on the role of various cell
surface receptors in the uptake of F. tularensis, the reader is
referred to an excellent review by Moreau and Mann (Moreau
and Mann, 2013). Our focus here will be limited to the receptors
involved in complement-dependent uptake of F. tularensis.
Complement component C3 was first shown to be important
for optimal uptake of F. tularensis by human monocyte-derived
macrophages (MDMs) by replenishing C3-depleted serum with
C3 protein (Clemens et al., 2005). This resulted in a C3
concentration-dependent uptake of bacteria. The importance of
C3 in the uptake of F. tularensis has since been confirmed by
several other groups (Dai et al., 2013; Brock and Parmely, 2017).
Antibody blocking of CR3 with anti-CD11b and anti-CD18
reduced the uptake of HS-opsonized F. tularensis by human
MDM (Clemens et al., 2005). Additional studies on blocking of
complement receptors with antibodies have demonstrated that
CR3 and CR4 are the predominant receptors involved in the
uptake of HS-opsonized F. tularensis by human macrophages
(Schulert and Allen, 2006; Schwartz et al., 2012). However,
blocking antibodies often show relatively modest effects in this
context. The use of siRNA to inhibit expression of CR3 in human
MDM has also demonstrated that CR3 is an important receptor
for the uptake of serum-opsonized SCHU S4 (Dai et al., 2013)
and is consistent with the observation that C3 deposited on
F. tularensis during HS opsonization is rapidly converted to iC3b.
Inactivated C3b, not C3b, is the primary ligand for CR3 and
CR4. CR1 does not appear to play a significant role in the uptake
of serum-opsonized F. tularensis by human MDM, based on
antibody blocking of CR1 (Schwartz et al., 2012).
Another experimental approach for determining important
receptor-ligand interactions in C3-mediated uptake of
F. tularensis has involved heat inactivation of HS to block
complement activation or selective depletion of individual
complement components, both of which yield greater effects on
uptake than receptor blocking with antibodies. Perhaps blocking
antibodies lack the affinity required to compete with high affinity
natural ligands. Alternatively, incomplete blocking by antibodies
to CRs may indicate that other receptors also mediate uptake of
serum-opsonized F. tularensis. For example, Class A scavenger
receptors have been shown to bind iC3b (Goh et al., 2010)
and have been implicated in the uptake of serum-opsonized
F. tularensis (Pierini, 2006; Geier and Celli, 2011). Balagopal et al.
(2006) suggested that Fcγ-receptors on human MDM could also
contribute to uptake of serum-opsonized F. novicida. A role for
CRIg in the uptake of serum-opsonized F. tularensis has not been
investigated. CRIg is a complement receptor expressed on tissue
macrophages which binds the beta chain of C3, allowing the
receptor to phagocytize both C3b- and iC3b-opsonized particles.
The receptor has been shown to be important for the clearance
of pathogens (Helmy et al., 2006; van Lookeren Campagne
et al., 2007). Thus, although our knowledge of all the receptors
that mediate the uptake of serum-opsonized F. tularensis may
be incomplete, iC3b and CR3 likely play dominate roles in
Francisella opsonophagocytosis by macrophages.
Complement C3-mediated uptake of F. tularensis is not
restricted to macrophages. Ben Nasr et al. showed that C3
is also required for increased uptake of F. tularensis by
human monocyte-derived dendritic cells. Opsonization with
C3-depeleted HS resulted in levels of uptake similar to those
observed with un-opsonized bacteria (Ben Nasr et al., 2006; Ben
Nasr and Klimpel, 2008). Blocking with antibodies to CD11b and
CD11c identified CR3 andCR4 as important for enhanced uptake
by dendritic cells (Ben Nasr et al., 2006). By contrast, blocking
Fc receptors had little effect (Ben Nasr et al., 2006). In similar
receptor blocking studies, Schwartz et al. (2012) found that CR1
(CD35) and CR3 (CD11b) mediated uptake of HS-opsonized
F. tularensis by human neutrophils (Schwartz et al., 2012). These
studies illustrate that different cells utilize a range of complement
receptors to phagocytize serum-opsonized F. tularensis.
EFFECTS OF COMPLEMENT ON
F. TULARENSIS INFECTION OF
MACROPHAGES
Complement C3-opsonization appears to have more effects
than simply increasing the number of F. tularensis bacteria
that are phagocytized. Clemens et al. showed that both non-
opsonized and HS-opsonized F. tularensis LVS were taken up
by a unique process, referred to as “looping phagocytosis,”
which involved spacious, asymmetric pseudopod loops (Clemens
et al., 2005, 2012). An O-antigen-deficient LVS mutant was also
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phagocytized via looping in the absence of serum. However,
the morphology of uptake of this serum-sensitive O-antigen
mutant was altered in the presence of C7-deficient serum, which
allowed for opsonization but prevented complement-mediated
bacteriolysis (Clemens et al., 2012). C7-deficient serum promoted
uptake of the mutant in very tight loops. As serum-sensitive O-
antigen mutants support increased C3-deposition (Clay et al.,
2008), the authors suggested that an increased interaction
between bacterial surface bound C3 peptides and macrophage
complement receptors likely led to closer physical interactions at
the host-microbe interface (Clemens et al., 2012). An important
unanswered question is whether this morphological change leads
to different signaling in the host cell.
Geier and Celli demonstrated that CR3 was important in the
uptake by mouse bone marrow-derived macrophages (BMM) of
HS-opsonized SCHU S4 (Geier and Celli, 2011). Uptake of HS-
opsonized SCHU S4 delayed the maturation of the phagosome
as measured by the expression of LAMP-1. Baudino et al. have
also reported a delay in phagosome maturation associated with
the uptake of C3-opsonized apoptotic cells (Baudino et al., 2014).
Uptake via CR3 decreased the proportion of SCHU S4 bacteria
that escaped phagosomes measured at 30min PI (Geier and
Celli, 2011). However, differences between phagosome escape of
HS-opsonized bacteria by wild-type BMM and CD11b-deficient
BMM were lost by 45min PI, suggesting the effect was only
temporary.
Geier and Celli also concluded that HS-opsonization
restricted the replication of the pathogen measured at 12 h
PI. Our own studies with human macrophages indicate
that intracellular replication rates of SCHU S4 in human
macrophages are not affected by C3-opsonization (Brock and
Parmely, 2017). SCHU S4 bacteria taken up in HS did not
evidence any impaired ability to replicate to high densities
within human primary macrophages. It should be noted that
the time required for maximum F. tularensis escape from
phagosomes appears to be greater in human THP-1 cells and
primary macrophages (Clemens et al., 2004) than is observed
in murine BMM (Geier and Celli, 2011), and this may explain
some of the differences between these studies. Similarly, the
percentage of HS-opsonized bacteria that ultimately do escape
the phagosome appears to be higher in human macrophages
(typically∼80%) (Clemens et al., 2004; Brock and Parmely, 2017)
than mouse macrophages (typically ∼55%) (Geier and Celli,
2011). Another distinction between these mouse and human
studies is the use of human serum as the source of opsonins in
both cases. This approach assumes that human C3 interacts with
human and mouse complement receptors in a similar manner
and that signaling from both species of receptors is also the
same.
Dai et al. reported that the binding of C3-opsonized SCHU
S4 to CR3 altered the human macrophage response to infection
by suppressing inflammatory cytokine production induced by
TLR2 (Dai et al., 2013). By comparing infection of MDM with
SCHU S4 in C3-depleted and C3-replenished human serum,
the investigators found that the presence of C3-opsonization
decreased the phosphorylation of MAP kinases ERK and
p38 and decreased levels of secreted TNF, IL-6 and IL-1β.
Serum opsonization of SCHU S4 also resulted in less NF-
κB phosphorylation and nuclear translocation. Using siRNA to
inhibit expression of CD11b or TLR2, they demonstrated that
TLR2 activated pro-inflammatory responses to F. tularensis and
that CR3 inhibited TLR2 signaling. CR3 inhibition of TLR2
signaling was mediated through phosphorylation of Lyn kinase.
These studies indicate that the binding and uptake of C3-
opsonized F. tularensis has a number of effects beyond the
promotion of phagocytosis. C3 mediates a different morphology
of uptake, significant changes in early host cell signaling
pathways, subtle changes in intracellular trafficking and even
altered survival of infected macrophages (Brock and Parmely
2017), which will now be discussed in more detail.
C3 CONTROLS MACROPHAGE SURVIVAL
DURING INFECTION WITH TYPE A
F. TULARENSIS
While studying infections of human MDM with F. tularensis
SCHU S4, we observed that large numbers of macrophages in
infected cultures died by 24 h PI and that cell death was C3-
dependent (Brock and Parmely, 2017). Death was rare among
macrophages that had been infected in the presence of heat-
inactivated or C3-depleted serum. Single cell analysis by confocal
microscopy revealed that a high cytosolic bacterial burden was
not required for C3-dependent macrophage death. Many cells
that bore only a few bacteria died as long as uptake had been
facilitated by the presence of fresh HS. Conversely, half of
macrophages that contained more than 100 bacteria did not
die by 24 h PI when bacteria were taken up in a C3-dependent
fashion. Some MDM in cultures that had been infected with
C3-opsonized SCHU S4 lacked any detectable bacteria, and
very few of these bystander cells died. Acknowledging that
differences in the extent of bacterial uptake existed between
the two opsonization conditions, we equalized initial uptake
of the pathogen in HS and C3-depleted HS by adjusting the
multiplicities of infection (MOI). When initial uptake levels
were equivalent, similar bacterial growth occurred under the
two conditions, but macrophage death was only seen in the
presence of C3. We concluded that high bacterial burden
was neither necessary nor sufficient for cell death induction,
which was confirmed by infections with the replication-deficient
SCHU S4 ∆purMCD mutant. Despite its limited intracellular
replication, the HS-opsonized ∆purMCD mutant strain escaped
the phagosome and induced cell death at levels equivalent to
those seen in wild type SCHUS4-infected cultures. C3-dependent
uptake alone did not explain the induction of macrophage
death, as shown by the failure of the phagosome escape-deficient
mutant SCHU S4 ∆fevR to induce death of MDM, despite C3
opsonization. These findings suggest that two conditions need to
be met for macrophage death. First, the cells must contain the
pathogen. Second, uptake must occur in a C3-dependent fashion.
While we do not yet know all of the details of this process, C3
appears to be emerging as an important factor in the induction
of macrophage death that is so commonly seen in tularemia
(Parmely et al., 2009).
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The experiments of Tam et al. (2014) reviewed above provide a
potential context for understanding how complement promotes
macrophage death following infection with type A F. tularensis.
This group demonstrated that cytosolic C3 peptides, likely in
the form of C3b, can activate NF-κB in a number of cell
types. If this cellular response was initiated by the sensing of
a cytosolic C3 peptide, as postulated by the authors, it would
provide a reasonable hypothesis for explaining what we have
observed during F. tularensis infections of human macrophages.
Accordingly, we suggest that C3 peptides, including iC3b, are
recognized in the cytosol of macrophages as molecular patterns
and that the response to them is directed toward cell death, rather
than NF-κB activation, by type A F. tularensis (Figure 3). This
pathogen has a well-established anti-inflammatory phenotype,
which includes its ability to inhibit NF-κB activation (Telepnev
et al., 2003, 2005; Bosio et al., 2007; Butchar et al., 2008; Chase
et al., 2009; Dotson et al., 2013; Bauler et al., 2014; Ghonime et al.,
2015; Putzova et al., 2017). C3-dependent uptake of F. tularensis
by CR3 further inhibits NF-κB activation and pro-inflammatory
gene expression in human macrophages (Dai et al., 2013).
Our prediction that C3 peptides induce macrophage death
after SCHU S4 entry into the cytosol rests, in part, on studies
with the phagosome escape SCHU S4 ∆fevR mutant. Strains
deficient in FevR have been used by others to determine the
importance of phagosome escape in various aspects of infection
of and immunity to F. tularensis (Wehrly et al., 2009; Long
et al., 2013). However, it should be noted that FevR is a global
transcriptional regulator and controls the expression of a number
of F. tularensis genes.
Our hypothesis would predict that C3 peptides enter the
cytosol with F. tularensis. Human serum-opsonized F. tularensis
bears covalently attached C3b and iC3b when it is taken up by
cells, although the fate of these peptides during their extended
stay in the phagosome is unknown. Phagosome escape by SCHU
S4 in human macrophages is not complete until 8 h PI. In this
context, it remains unclear whether the pathogen contributes
more to macrophage death induction than simply transporting
the relevant C3 peptides into the cytosol, but we expect that it
does. Tam et al. (2014) were able to elicit a NF-κB response in
HEK293T cells by simply transfecting the cells with latex beads
opsonized with the purified complement components C3, FB
and FD. This would suggest that the NF-κB response does not
require a microbial component and that cytosolic C3 peptides
may be sufficient for this response. Tam et al. (2014) did not
report on the viability of the host cell following the transfection
of C3 peptides into the cytosol. Thus, it remains to be determined
if cytosolic C3 or cytosolic C3 fragments alone are sufficient
to trigger macrophage death. Because both F. tularensis itself
and CR3 engagement are capable of inhibiting NF-κB activation
(Telepnev et al., 2003; Dai et al., 2013; Putzova et al., 2017), we
propose that the response to cytosolic C3 in F. tularensis-infected
macrophages is diverted to a cell death pathway (Figure 3). This
would explain the requirement for C3-opsonization and align
our findings with the C3 sensing model proposed by Tam and
colleagues.
Testing the hypothesis that cell death is initiated by the
combined effects of C3 peptides and F. tularensis may be best
FIGURE 3 | Hypothetical model of serum-opsonized F. tularensis-induced
human macrophage death. Human serum-opsonized F. tularensis delivers C3
peptides into the cytosol of macrophages upon phagosome escape of the
pathogen. Cytosolic F. tularensis and sensing of cytosolic C3 peptides trigger
macrophage death.
undertaken by the direct delivery of these components into the
cytosol of macrophages by methods such as those described by
Meyer et al. (2015) or Wu et al. (2015). These experimental
approaches would allow one to isolate the effects of the cytosolic
microenvironment from those stages of infection preceding
phagosome escape and evaluate more precisely the nature of C3,
the bacterial components and the host cell recognition process
that combines to trigger macrophage death.
What role does CR3, which mediates the uptake of C3-
opsonized SCHU S4 by human macrophages, play in signaling
cell death? Two observations may be relevant. Dai et al. (2013)
showed that humanMDM infected with C3-opsonized SCHU S4
produced decreased amounts of IL-1β, a finding we confirmed
in our own studies (Brock and Parmely, 2017). Release of IL-
1β requires inflammasome-mediated caspase-1 activation, which
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is not a characteristic of type A F. tularensis (Dotson et al.,
2013; Ghonime et al., 2015). Thus, it is unlikely that CR3
binding of C3-opsonized SCHU S4 induces caspase-1-mediated
pyroptosis in human macrophages as has been reported for
mouse macrophages infected with F. novicida (Mariathasan et al.,
2005; Henry et al., 2007; Peng et al., 2011). A second finding
is also relevant. When we first infected human MDM at high
MOI with SCHU S4 opsonized with C3-depleted serum and then
infected these cells with C3-opsonized SCHU S4 ∆fevR mutant
bacteria, the infected macrophages remained viable. Secondary
infection with C3-opsonized wild type SCHU S4 resulted in
macrophage death. Likewise, infection with C3-opsonized SCHU
S4 ∆fevR alone also did not induce macrophage death, whereas
C3-opsonized wild type SCHU S4 alone did. This illustrates
that CR3 engagement is not a sufficient death signal, even
in macrophages infected with high numbers of intracellular
bacteria lacking C3 peptides. A reasonable explanation for
these findings is that macrophage death requires both cytosolic
F. tularensis and cytosolic C3 peptides. While it cannot be
ruled out that CR3 signaling (Dai et al., 2013) contributes
to macrophage death, there is also no reason to assume
that CR3-mediated uptake of C3-opsonized F. tularensis is
required for cell death induction. CR3 may simply be the most
efficient receptor for assuring a high frequency of infected
cells.
Although a putative C3 sensor remains to be characterized,
two likely ligands—C3b and iC3b—are predicted by available
information. First, Tam and his colleagues implied that the ligand
was C3b by the few components—C3, FB and FD—that were
required for opsonizing latex beads capable of activating NF-
κB following their transfection into cells (Tam et al., 2014).
Second, when F. tularensis SCHU S4 is opsonized with HS,
iC3b is the predominant peptide covalently attached to the
organism (Ben Nasr and Klimpel, 2008; Clay et al., 2008; Brock
and Parmely, 2017). This is consistent with the high levels of
uptake of C3-opsonized F. tularensis by human macrophages
being mediated by CR3 (Clemens et al., 2005; Schwartz et al.,
2012; Dai et al., 2013), which shows high affinity for iC3b
(Table 1).
Previous studies of mice infected with type A F. tularensis
revealed a caspase-3-dependent pathway of macrophage death
(Parmely et al., 2009; Wickstrum et al., 2009). However, to
date, we have been unable to determine the cell death pathway
activated by C3-opsonized SCHU S4 in human MDM. The
extended period of time between infection with F. tularensis
and macrophage death has suggested to some that a causal
relationship exists between achieving a sufficient intracellular
bacterial burden and cell death induction. However, recently
published findings (Brock and Parmely, 2017) described above
are inconsistent with this interpretation. If the kinetics of cell
death reflects an apoptotic process, which can take up to 24 h
(Saraste and Pulkki, 2000), then the delay in the appearance
of overt signs of cell death (e.g., LDH release) may reflect the
variability in apoptosis induction among individual cells, the
complex nature of signaling pathways or the lengthy degradative
processes necessary for loss of membrane integrity leading to
LDH release.
Francisella tularensis is likely to encounter the complement
system quite early in infection, given the range of cells that
produce complement components and the high concentrations
of these components in body fluids, especially plasma, alveolar
fluids and inflammatory exudates (Schenkein and Genco, 1978;
Watford et al., 2000; Holers, 2014; Lubbers et al., 2017).
Complement activation by extracellular microbial pathogens
has traditionally been viewed as benefiting the host by
mediating clearance, leukocyte chemotaxis and altered vascular
permeability at sites of infection. However, this view needs
to be balanced by recent reports that F. tularensis utilizes
complement to its own advantage by avoiding many complement
effector mechanisms, regulating innate immune cell activation
and controlling host cell viability to promote its own survival,
intracellular replication and dissemination. Caution is urged in
considering therapeutic approaches to infection that might affect
complement activation by F. tularensis. Clearly, the pathogen
has a complicated and largely mysterious relationship with the
complement system that deserves additional study to appreciate
fully its role in tularemia pathogenesis.
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